NetworkNewsBreaks – Pressure BioSciences Inc. (P
Post# of 1354
(Total Views: 114)
Posted On: 11/09/2018 7:38:56 PM
NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Milestone in Development of Ultra Shear Technology Platform
Pressure BioSciences (OTCQB: PBIO) today announced that significant progress has been made in its development program for its proprietary Ultra Shear Technology (“UST”) platform. Per the update, the company has completed development of the first working prototype of its UST System and initiated a program to develop a proprietary method to make water soluble oils for use in multiple markets. “We believe there are significant opportunities for UST-processed nanoemulsion products in addition to the rapidly growing CBD market. Examples include large scale premium dairy and other high volume food products, as well as cosmetics, industrial lubricants, nutraceuticals, and pharmaceuticals,” Richard T. Schumacher, president and CEO of PBIO, stated in the news release. “We are currently focused on developing collaborative projects with multiple companies and research organizations to address different product and market opportunities worldwide. These programs should lead to revenue generating products and services in the very near future.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Pressure BioSciences (OTCQB: PBIO) today announced that significant progress has been made in its development program for its proprietary Ultra Shear Technology (“UST”) platform. Per the update, the company has completed development of the first working prototype of its UST System and initiated a program to develop a proprietary method to make water soluble oils for use in multiple markets. “We believe there are significant opportunities for UST-processed nanoemulsion products in addition to the rapidly growing CBD market. Examples include large scale premium dairy and other high volume food products, as well as cosmetics, industrial lubricants, nutraceuticals, and pharmaceuticals,” Richard T. Schumacher, president and CEO of PBIO, stated in the news release. “We are currently focused on developing collaborative projects with multiple companies and research organizations to address different product and market opportunities worldwide. These programs should lead to revenue generating products and services in the very near future.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Pressure Biosciences (PBIO) Stock Research Links
Scroll down for more posts ▼